KANGIO (BIVALIRUDIN) INJECTION
DEAD

Add to watchlist:

No watchlists yet
View on USPTO

KANGIO (BIVALIRUDIN) INJECTION Trademark

Serial Number: 86851053

KANGIO (BIVALIRUDIN) INJECTION is a trademark filed by Eagle Pharmaceuticals, Inc. on December 16, 2015. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Owner Contact Info

Eagle Pharmaceuticals, Inc. (30 trademarks)

50 Tice Boulevard, Suite 315
Woodcliff Lake, NJ 07677

Entity Type: 03

Trademark Details

Filing Date

December 16, 2015

Registration Date

Not Registered

Published for Opposition

May 31, 2016

Goods & Services

BIVALIRUDIN PREPARATIONS FOR PHARMACEUTICAL PURPOSES

Filing History

ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Apr 27, 2026 ASCK
ABANDONMENT NOTICE MAILED - AFTER PUBLICATION
Aug 4, 2016 MAB5
ABANDONMENT - AFTER PUBLICATION
Aug 4, 2016 ABN5
WITHDRAWN FROM ISSUE - PETITIONS OFFICE REQUEST
Jul 18, 2016 ISPO
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 31, 2016 NPUB
PUBLISHED FOR OPPOSITION
May 31, 2016 PUBO
TEAS EXPRESS ABANDONMENT RECEIVED
May 23, 2016 EXAR
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
May 11, 2016 NONP
LAW OFFICE PUBLICATION REVIEW COMPLETED
Apr 28, 2016 PREV
ASSIGNED TO LIE
Apr 21, 2016 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 9, 2016 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 8, 2016 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 8, 2016 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Apr 8, 2016 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Apr 3, 2016 GNRN
NON-FINAL ACTION E-MAILED
Apr 3, 2016 GNRT
NON-FINAL ACTION WRITTEN
Apr 3, 2016 CNRT
ASSIGNED TO EXAMINER
Apr 2, 2016 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 21, 2015 NWOS
NEW APPLICATION ENTERED
Dec 19, 2015 NWAP